This page brings together the Agency's latest information on HIV and AIDS.
the ten newest and recently updated medicines authorised for the treatment of HIV and AIDS in the European Union (EU);
the most recent opinions on medicines against HIV and AIDS that are pending authorisation by the European Commission (EC);
the latest HIV- and AIDS-related news and press releases;
the Agency's events on HIV- and AIDS-related topics.
New and recently updated medicines
Opinions pending EC decision
EMA supports World AIDS Day on 1 December ... Read more
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 September 2014
Fifteen new medicines and three extensions of indication recommended for approval ... Read more
This page provides an overview of the opinions adopted at the June 2014 meeting of the Committee for Medicinal Products for Human Use (CHMP) and other important outcomes. ... Read more
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorisation for Tivicay in combination with other antiretroviral medicines for the treatment of adults and adolescents over 12 years of age infected with human immunodeficiency virus (HIV). ... Read more
Consultation on updated guideline on clinical development of medicines for treatment of HIV infection
The European Medicines Agency (EMA) has released a draft revision of its guideline on the clinical development of medicines for the treatment of human-immunodeficiency-virus (HIV) infection, for a six-month public consultation. ... Read more
The paediatric HIV expert group meeting is being held to identify the best possible development approaches for existing and new medicines in the field of HIV in childhood and adolescence for paediatric investigation plans. ... Read more